Proper classification determines the amount of work involved
Whether it's SaMD or software embedded in a product: Qualification, classification, and safety class determine how much evidence is actually required.
Manufacturers should not view software development as a series of isolated, stand-alone documentation artifacts that need only be traceable within the development process. The software documentation must provide third parties with insight into the software’s impact on the product’s safety and performance, the elements of the software and their interactions, as well as the planned and implemented activities of the software life cycle.
Medical Device Software (MDSW) is the term defined in MDCG 2019-11 for software that is itself a medical device (SaMD) and software that is part of a medical device.
Metecon assists with the classification of software, establishes development, change management, and problem-solving processes in accordance with IEC 62304 as needed, creates and links requirements, identifies risks within the product context, develops or assists with verification planning and execution, and creates or assists with software release documentation. This results in comprehensive traceability documentation that links development, regulatory requirements, and product maintenance throughout the entire life cycle. The added value begins in the planning phase, extends through the requirements phase to release—and continues to have an impact as changes are made in response to market feedback and innovation.
Intended for: Heads of regulatory affairs, regulatory managers with MDSW responsibilities, and software and development managers with shared regulatory responsibilities. Executive management of SaMD manufacturers. QM managers and PRRCs.
Requirements, architecture, testing, and approvals do not interlock consistently. Documentation is not created completely or in a consistent manner.
Requirements and risks are not consistently linked to tests, approvals, and evidence. Gaps only become apparent during an audit. Full coverage of the requirements cannot be demonstrated. This makes it difficult or even impossible to perform regression tests.
New versions and updates create additional documentation and reconciliation work because the data available for evaluating the changes is not traceable or sufficient. This can affect the implementation of the change and the acceptance of the change (regression testing).
Whether it's SaMD or software embedded in a product: Qualification, classification, and safety class determine how much evidence is actually required.
MDSW encompasses various configurations, each with its own regulatory requirements. Correctly classifying the software from a regulatory perspective is the first step toward robust supporting documentation. The same process model also applies to IVD software (under the IVDR): software for, in, and as an IVD—including, among other things, a performance evaluation instead of a clinical evaluation in the supporting documentation.
Standalone software that is itself a medical device and is not part of another product. Its classification as a medical device distinguishes the software in question from non-medical devices.
Classification into risk classes according to the MDR determines the applicable regulatory requirements and the resulting level of evidence required.
decision on whether or not the product is a medical device and its risk class according to MDR Annex VIII (specifically Rule 11) or IVDR, taking into account MDCG 2019-11, clearly justified and documented.
Clear identification of the software interfaces to other software systems. Clear delineation of the software from other software systems. Identification of the intended runtime environment for the software (Execution Environment).
Software documentation that complies with requirements, serving as a robust component of the technical documentation (Link: Technical Documentation →), and evidence of compliance with regulatory requirements, including for international submissions.
In distributed systems (e.g., server-client architecture), we clearly define the medical device and document it accordingly in accordance with IEC 82304-1 or IEC 62304.
Software as an integral part of a medical device, embedded within the device (e.g., firmware). Architecture, SOUP handling, and system interfaces are key elements of the verification process. Here, Metecon provides support for a comprehensive mapping of the software within the 60601-1 context (PEMS/PESS), both in the architectural description and in the requirements domain, as well as in documenting the integration of the software.
Clear identification of the interface between SOUP and software, including identifying and acknowledging the role of SOUP in architecture, configuration management, and PMS.
External interfaces for data transmission (such as USB or Ethernet interfaces) must be evaluated from a cybersecurity perspective in the context of the product. This documentation is also used to demonstrate compliance with regulatory requirements. (Link: Cybersecurity →)
Software verification in the context of the overall product, consistent with planning, metrics, completeness, and clear documentation, and seamlessly integrated into the product's overall documentation.
Software that supports or complements medical devices in a medical context. Only after qualification and classification can it be determined whether and to which extent the software is subject to regulation.
Medical device: yes/no—clearly determined and justified based on the intended purpose and the classification rules.
A precise definition of the intended purpose delineates functions and responsibilities and prevents costly misclassifications.
IEC 62304 governs the software life cycle process. Integrating software aspects into the process landscape is a key element for the successful implementation of IEC 62304. Metecon can assist in designing the process interfaces, thereby ensuring optimal communication between departments.
Determine the qualification and classification of the software as a product and its safety class in accordance with regulatory requirements (e.g., EN 62304 or other country-specific / international regulations)—the basis for determining the appropriate level of effort.
EN 62304 specifies requirements for the content expected in the development plan. The software development plan maps out the processes and activities involved in software development, as well as downstream activities.
Assess software risks, derive risk control measures, and link them to risk management in accordance with ISO 14971.
Specify software requirements and architecture to ensure regulatory compliance, including SOUP and interfaces.
Traceability, establishment of coding guidelines, and integration of unit test criteria. Support in identifying and validating the software tools used.
The backbone of the traceability structure: Consistently linking requirements, risks, tests, and development results so that it can be verified at any time that every requirement and every risk has been tested and addressed in the release. Support for test planning, test specification, and test execution. Support for the evaluation of test results within the regulatory context.
Keep releases, changes, and updates under control with a transparent assessment of the impact of changes, without increasing coordination efforts. Support for the release of external software development.
Requirements ↔ risks ↔ tests ↔ releases are consistently linked. This turns documents into a robust, audit-ready documentation structure.
We translate regulatory requirements into practical, comprehensive supporting documentation—no patchwork of individual documents.
35+ software files and 25+ FDA submissions: robust evidence for the EU and the U.S. from a single source.
Risk management, usability engineering, V&V, cybersecurity, AI, and technical documentation are consistently interwoven within the verification structure.
The selection criteria are based on the strengths of leading providers: up-to-date knowledge of standards, scalable support, and practical, domain-specific consulting.
Metecon meets these benchmarks and combines them with evidence-based documentation tailored to the needs of the EU and international markets.
We cover cybersecurity, AI regulation (AI Act), and software validation on dedicated pages—linked here as components of the MDSW evidence structure.
Qualification, classification, and a robust regulatory strategy for the EU (MDR/IVDR) and internationally (including the FDA).
Design of software life cycle processes: from planning, through requirements, architecture, verification, and validation, to maintenance and PMS.
Analysis of interfaces within the existing process landscape with regard to the software life cycle, risk management, information security, and usability.
Tool validation: Validation of the tools used in the software life cycle (compilers, bug tracking, CI infrastructure).
DiGA: Digital health applications approved by the BfArM that can be prescribed by a physician. DiPA: Digital care applications to support daily care activities, subject to BfArM review procedures.
Review of existing documentation for gaps in compliance with the MDR/IVDR and relevant standards—with specific recommendations for action.
We support your interactions with Notified Bodies and regulatory authorities in Europe and with international agencies (e.g., the FDA)—from preparation and coaching to comprehensive 360° support for approvals and audits.
Training sessions and workshops for your development, quality management, and regulatory teams.
We establish robust development, software, and QM processes (ISO 13485) for MDSW and help to maintain them continuously.
We support you with all regulatory tasks throughout your development process—from a single source, across the entire life cycle.
Integration of security requirements and evidence into the release logic (IEC 81001-5-1).
Learn more →
Proper integration and validation of UI- and use-related risks (IEC 62366-1).
Learn more →
Consistent documentation of software risks, measures, and residual risks (ISO 14971).
Learn more →
Alignment of test strategy consistently with requirements and risks.
Learn more →
AI-based software requires robust documentation to support its development, changes, and monitoring (EU AI Act).
Learn more →

Thorsten Stumpf is one of the software specialists on the Regulatory Affairs & Technical Documentation team and has an extensive network within the industry on this topic. Thorsten has many years of experience in the regulatory classification of medical device software, including the review of software life cycle documentation in accordance with IEC 62304. He assists manufacturers with classification, regulatory strategy, and technical documentation for MDSW.
IEC 62304 / 82304-1 • 35+ software files• 25+ FDA submissions“It is not the volume of documents that determines medical device software, but rather their end-to-end traceability: requirements, risk management, verification, validation, releases, and PMS—all robustly linked. We build this structure from the very beginning in accordance with IEC 62304, IEC 82304-1, and IEC 60601-1. For a system that supports the entire life cycle."
– Thorsten Stumpf, Principal Expert Software & AI · RAC Devices, Metecon
MDSW is the EU umbrella term and encompasses software that is a standalone medical device (SaMD) as well as software that is part of a medical device. The intended use is the decisive factor: it is the medical intended use that makes software a medical device.
Ideally, the planned documentation structure—as required by regulations—should already be outlined in the development plan. Activities carried out later can be extremely costly and time-consuming.
A documentation structure is considered robust if it comprehensively and fully addresses regulatory requirements—not if documents merely exist side by side.
The class (A/B/C) is based on the potential harm resulting from software failure—assessed in light of the risk context, risks, and risk control measures. Appropriate measures can lower the software security class. A lower class requires less information to be included in the submission.
By consistently linking requirements, risks, tests, and development results, and by ensuring and maintaining traceability across all development stages, it can be demonstrated that every requirement and every risk has been verified and addressed in the release.
Through a defined change and approval process with a traceable procedure model, taking into account the risk context and the feasibility of the change.
The process structure integrates these disciplines as interconnected inputs and outputs: software risks into risk management; hazard-related use scenarios from usability engineering into risk analysis; identified attack scenarios from cybersecurity into risk analysis; and preclinical findings as the basis for the clinical evaluation/performance evaluation.
The effort required depends on the specific circumstances, safety class, level of evidence, regulatory capabilities, and target markets (e.g., EU/FDA). During a free initial consultation, we’ll assess your case and provide a reliable framework.
Start with a free initial consultation—we’ll classify your software (SaMD or software-as-a-device), determine the safety class, and outline the documentation structure for the EU and FDA.
Your contact:
Milan Weiß
Sales Manager
T: +49 621 123469-040
milan.weiss@metecon.de
